HL7 BE Laboratory WG Implementation Guide
1.0.0 - STU

This page is part of the HL7 Belgium FHIR Implementation Guide - Lab related profiles (v1.0.0: Trial Use) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Structured Antibiogram in collection bundle - JSON Representation

Raw json | Download


{
  "resourceType" : "Bundle",
  "id" : "antibiogramAsBundleNN",
  "identifier" : {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:uuid:0c3151bd-1cbf-4d99-b04d-cd9187a4c6e0"
  },
  "type" : "collection",
  "entry" : [
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d34",
      "resource" : {
        "resourceType" : "DiagnosticReport",
        "id" : "diagnosticreport50",
        "meta" : {
          "versionId" : "1",
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-laboratory-report"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "system" : "https://www.ehealth.fgov.be/lab-report/diagnostic-report-id",
            "value" : "11530231003.2015110413180000000"
          }
        ],
        "basedOn" : [
          {
            "reference" : "ServiceRequest/servicerequest50"
          }
        ],
        "status" : "final",
        "category" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
                "code" : "LAB",
                "display" : "Laboratory"
              },
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
                "code" : "MB",
                "display" : "Microbiology"
              }
            ]
          }
        ],
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "18769-0",
              "display" : "Microbial susceptibility tests Set"
            }
          ],
          "text" : "Microbial susceptibility tests"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-03T13:18:00+01:00",
        "issued" : "2015-11-04T13:18:00+01:00",
        "performer" : [
          {
            "reference" : "Organization/organization10"
          }
        ],
        "resultsInterpreter" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "specimen" : [
          {
            "reference" : "Specimen/specimen50"
          }
        ],
        "result" : [
          {
            "reference" : "Observation/org51"
          },
          {
            "reference" : "Observation/org52"
          },
          {
            "reference" : "Observation/dr50-mrsa"
          },
          {
            "reference" : "Observation/dr50-mrgn"
          }
        ],
        "conclusion" : "This is our conclusion"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d36",
      "resource" : {
        "resourceType" : "Specimen",
        "id" : "specimen50",
        "meta" : {
          "versionId" : "1",
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-specimen-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "system" : "https://www.GTL-LABO.be/",
            "value" : "1"
          }
        ],
        "status" : "available",
        "type" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "258529004",
              "display" : "Throat swab"
            }
          ],
          "text" : "A string can be added to nuance or explain."
        },
        "receivedTime" : "2015-11-04",
        "note" : [
          {
            "text" : "Some extra relevant information concerning the specimen"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d37",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "73960-7",
              "display" : "Bacteria identified in Mouth by Culture"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "243301005",
              "display" : "Morganella morganii"
            }
          ]
        },
        "specimen" : {
          "reference" : "Specimen/specimen50"
        },
        "hasMember" : [
          {
            "reference" : "Observation/org51-ampicilin"
          },
          {
            "reference" : "Observation/org51-trimethoprim-sulfamethoxazole"
          },
          {
            "reference" : "Observation/org51-nitrofurantoin"
          },
          {
            "reference" : "Observation/org51-cefuroxime"
          },
          {
            "reference" : "Observation/org51-gentamicin"
          },
          {
            "reference" : "Observation/org51-colistin"
          },
          {
            "reference" : "Observation/org51-temocillin"
          },
          {
            "reference" : "Observation/org51-fosfomycin"
          },
          {
            "reference" : "Observation/org51-levofloxacin"
          },
          {
            "reference" : "Observation/org51-ofloxacin"
          },
          {
            "reference" : "Observation/org51-amoxicillin-clavulanate"
          },
          {
            "reference" : "Observation/org51-amikacin"
          },
          {
            "reference" : "Observation/org51-piperacillin-tazobactam"
          },
          {
            "reference" : "Observation/org51-ceftriaxone"
          },
          {
            "reference" : "Observation/org51-cefotaxime"
          },
          {
            "reference" : "Observation/org51-ceftazidime"
          },
          {
            "reference" : "Observation/org51-meropenem"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d38",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ampicilin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "29-9",
              "display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
            }
          ],
          "text" : "Ampicillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d39",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-trimethoprim-sulfamethoxazole",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "516-5",
              "display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Trimethoprim+Sulfamethoxazole"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d40",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-nitrofurantoin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "363-2",
              "display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Nitrofurantoin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d41",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-cefuroxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "51774-8",
              "display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefuroxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d42",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-gentamicin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "267-5",
              "display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Gentamicin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d43",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-colistin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "205-5",
              "display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Colistin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d44",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-temocillin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "492-9",
              "display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Temocillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d45",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-fosfomycin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "25653-7",
              "display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Fosfomycin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d46",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-levofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20396-8",
              "display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Levofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d47",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "375-6",
              "display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d48",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-amoxicillin-clavulanate",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20-8",
              "display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amoxicillin+Clavulanate"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d49",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-amikacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "12-5",
              "display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amikacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d50",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-piperacillin-tazobactam",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "412-7",
              "display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Piperacillin+Tazobactam"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d51",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ceftriaxone",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "141-2",
              "display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftriaxone"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d52",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-cefotaxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "108-1",
              "display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefotaxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d53",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ceftazidime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "133-9",
              "display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftazidime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d54",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-meropenem",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "6652-2",
              "display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Meropenem"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d55",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "73960-7",
              "display" : "Bacteria identified in Mouth by Culture"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "112283007",
              "display" : "Escherichia coli"
            }
          ]
        },
        "specimen" : {
          "reference" : "Specimen/specimen50"
        },
        "hasMember" : [
          {
            "reference" : "Observation/org52-ampicilin"
          },
          {
            "reference" : "Observation/org52-trimethoprim-sulfamethoxazole"
          },
          {
            "reference" : "Observation/org52-nitrofurantoin"
          },
          {
            "reference" : "Observation/org52-cefuroxime"
          },
          {
            "reference" : "Observation/org52-gentamicin"
          },
          {
            "reference" : "Observation/org52-colistin"
          },
          {
            "reference" : "Observation/org52-temocillin"
          },
          {
            "reference" : "Observation/org52-fosfomycin"
          },
          {
            "reference" : "Observation/org52-levofloxacin"
          },
          {
            "reference" : "Observation/org52-ofloxacin"
          },
          {
            "reference" : "Observation/org52-amoxicillin-clavulanate"
          },
          {
            "reference" : "Observation/org52-amikacin"
          },
          {
            "reference" : "Observation/org52-piperacillin-tazobactam"
          },
          {
            "reference" : "Observation/org52-ceftriaxone"
          },
          {
            "reference" : "Observation/org52-cefotaxime"
          },
          {
            "reference" : "Observation/org52-ceftazidime"
          },
          {
            "reference" : "Observation/org52-meropenem"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d56",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ampicilin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "29-9",
              "display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d57",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-trimethoprim-sulfamethoxazole",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "516-5",
              "display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Trimethoprim+Sulfamethoxazole"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d58",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-nitrofurantoin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "363-2",
              "display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Nitrofurantoin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d59",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-cefuroxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "51774-8",
              "display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefuroxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d60",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-gentamicin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "267-5",
              "display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Gentamicin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d61",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-colistin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "205-5",
              "display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Colistin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d62",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-temocillin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "492-9",
              "display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Temocillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d63",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-fosfomycin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "25653-7",
              "display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Fosfomycin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d64",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-levofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20396-8",
              "display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Levofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d65",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "375-6",
              "display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d66",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-amoxicillin-clavulanate",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20-8",
              "display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amoxicillin+Clavulanate"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d67",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-amikacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "12-5",
              "display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amikacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d68",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-piperacillin-tazobactam",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "412-7",
              "display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Piperacillin+Tazobactam"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d69",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ceftriaxone",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "141-2",
              "display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftriaxone"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d70",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-cefotaxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "108-1",
              "display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefotaxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d71",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ceftazidime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "133-9",
              "display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftazidime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d72",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-meropenem",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "6652-2",
              "display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Meropenem"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d80",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "dr50-mrsa",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "35492-8",
              "display" : "Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection"
            }
          ],
          "text" : "MRSA"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueString" : "negative"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d81",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "dr50-mrgn",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "78702-8",
              "display" : "Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture"
            }
          ],
          "text" : "MRGN"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueString" : "negative"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d72",
      "resource" : {
        "resourceType" : "Organization",
        "id" : "organization10",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-organization"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "type" : {
              "coding" : [
                {
                  "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
                  "code" : "MD",
                  "display" : "Medical License number"
                }
              ]
            },
            "system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
            "value" : "81165343998"
          }
        ],
        "active" : true,
        "type" : [
          {
            "coding" : [
              {
                "system" : "https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty",
                "code" : "orglaboratory"
              }
            ]
          }
        ],
        "name" : "GTL - General Testing Laboratory",
        "telecom" : [
          {
            "system" : "phone",
            "value" : "322675199",
            "use" : "work"
          }
        ],
        "address" : [
          {
            "extension" : [
              {
                "url" : "http://hl7.org/fhir/StructureDefinition/language",
                "valueCode" : "nl"
              }
            ],
            "use" : "work",
            "type" : "both",
            "text" : "Vulcansstraat 120, 1000 Brussel",
            "line" : [
              "Vulcansstraat 120"
            ],
            "_line" : [
              {
                "extension" : [
                  {
                    "url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName",
                    "valueString" : "Vulcansstraat"
                  },
                  {
                    "url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber",
                    "valueString" : "120"
                  }
                ]
              }
            ],
            "city" : "Brussel",
            "postalCode" : "1000",
            "country" : "BE"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d73",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "practitioner11",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
            "value" : "554488997"
          }
        ],
        "name" : [
          {
            "use" : "official",
            "family" : "Davoust",
            "given" : [
              "Nicolas"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "nicolas.davoust@gtl.be",
            "use" : "work"
          },
          {
            "system" : "phone",
            "value" : "022675198",
            "use" : "work"
          },
          {
            "system" : "fax",
            "value" : "022675209",
            "use" : "work"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d74",
      "resource" : {
        "resourceType" : "Patient",
        "id" : "patient1",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-patient"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin",
            "value" : "79121137740"
          }
        ],
        "active" : true,
        "name" : [
          {
            "family" : "La Paradisio",
            "given" : [
              "Josephine",
              "Nessa"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "nessa.laparadisio@belgium.be"
          },
          {
            "system" : "phone",
            "value" : "+322476792979",
            "use" : "mobile"
          },
          {
            "system" : "phone",
            "value" : "+3226718655",
            "use" : "home"
          },
          {
            "system" : "phone",
            "value" : "+322476799",
            "use" : "work"
          }
        ],
        "gender" : "female",
        "birthDate" : "1979-12-11",
        "_birthDate" : {
          "extension" : [
            {
              "url" : "http://hl7.org/fhir/StructureDefinition/patient-birthTime",
              "valueDateTime" : "1979-12-11T13:28:17-05:00"
            }
          ]
        },
        "address" : [
          {
            "use" : "home",
            "type" : "both",
            "text" : "Sloordelle 42, 1160 Oudergem",
            "line" : [
              "Sloordelle 42"
            ],
            "city" : "Oudergem",
            "postalCode" : "1160",
            "country" : "BE"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d75",
      "resource" : {
        "resourceType" : "ServiceRequest",
        "id" : "servicerequest50",
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "system" : "https://www.GTL-LABO.be/orderingsystem",
            "value" : "12334546"
          }
        ],
        "status" : "active",
        "intent" : "order",
        "category" : [
          {
            "coding" : [
              {
                "system" : "http://snomed.info/sct",
                "code" : "108252007",
                "display" : "Laboratory procedure"
              }
            ]
          }
        ],
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "authoredOn" : "2015-11-01T14:41:00+01:00",
        "requester" : {
          "reference" : "Practitioner/practitioner1"
        },
        "specimen" : [
          {
            "reference" : "Specimen/specimen50"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d76",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "practitioner1",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
          ]
        },
        "text" : {
          "status" : "empty",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
            "value" : "18749704477"
          }
        ],
        "name" : [
          {
            "use" : "official",
            "family" : "Pulaski",
            "given" : [
              "Katherine"
            ],
            "suffix" : [
              "MD"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "katherine.pulaski@enterprisehospital.be",
            "use" : "work"
          },
          {
            "system" : "phone",
            "value" : "022675198",
            "use" : "work"
          },
          {
            "system" : "fax",
            "value" : "022675209",
            "use" : "work"
          }
        ],
        "address" : [
          {
            "use" : "home",
            "text" : "Jupiterlaan 5, 1853 Grimbergen",
            "line" : [
              "Jupiterlaan 5"
            ],
            "city" : "Grimbergen",
            "postalCode" : "1853",
            "country" : "BE"
          }
        ]
      }
    }
  ]
}